SI-Bone Inc (NASDAQ:SIBN) Shares Sold by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC lessened its position in SI-Bone Inc (NASDAQ:SIBN) by 13.8% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 75,226 shares of the company’s stock after selling 12,082 shares during the quarter. Commonwealth Equity Services LLC’s holdings in SI-Bone were worth $1,329,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of SIBN. First Light Asset Management LLC purchased a new stake in shares of SI-Bone in the 2nd quarter valued at $13,248,000. BlackRock Inc. raised its holdings in shares of SI-Bone by 70.7% in the 2nd quarter. BlackRock Inc. now owns 1,120,294 shares of the company’s stock valued at $22,787,000 after buying an additional 463,874 shares during the period. Meridian Investment Counsel Inc. purchased a new stake in shares of SI-Bone in the 2nd quarter valued at $7,813,000. Capital Bank & Trust Co purchased a new stake in shares of SI-Bone in the 2nd quarter valued at $5,249,000. Finally, Vanguard Group Inc. raised its holdings in shares of SI-Bone by 65.5% in the 2nd quarter. Vanguard Group Inc. now owns 563,111 shares of the company’s stock valued at $11,454,000 after buying an additional 222,788 shares during the period. Hedge funds and other institutional investors own 45.43% of the company’s stock.

SIBN stock opened at $17.92 on Thursday. The company has a current ratio of 12.00, a quick ratio of 11.55 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $454.67 million and a PE ratio of -25.24. SI-Bone Inc has a 12-month low of $14.08 and a 12-month high of $23.03. The business’s fifty day moving average price is $17.16 and its 200 day moving average price is $18.01.

SI-Bone (NASDAQ:SIBN) last posted its quarterly earnings data on Monday, November 11th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.36) by ($0.10). The firm had revenue of $16.18 million during the quarter. SI-Bone had a negative net margin of 46.59% and a negative return on equity of 84.84%. Research analysts predict that SI-Bone Inc will post -1.31 EPS for the current fiscal year.

In other SI-Bone news, insider Anthony J. Recupero sold 1,400 shares of the company’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $19.45, for a total transaction of $27,230.00. Also, major shareholder Skyline Venture Partners V. Lp sold 152,424 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $18.40, for a total value of $2,804,601.60. The disclosure for this sale can be found here. Insiders sold a total of 383,524 shares of company stock worth $7,185,937 in the last quarter. Company insiders own 38.80% of the company’s stock.

Separately, ValuEngine downgraded SI-Bone from a “buy” rating to a “hold” rating in a report on Monday, November 4th.

SI-Bone Profile

SI-BONE, Inc, a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.

Recommended Story: How a Strangle Strategy is different from a Straddle Strategy

Want to see what other hedge funds are holding SIBN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SI-Bone Inc (NASDAQ:SIBN).

Institutional Ownership by Quarter for SI-Bone (NASDAQ:SIBN)

Receive News & Ratings for SI-Bone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SI-Bone and related companies with MarketBeat.com's FREE daily email newsletter.